Kathy Miller
Kathy Miller

Ballvé Lantero Professor of Oncology, IU School of Medicine, Associate director of clinical research, Indiana University Melvin and Bren Simon Cancer Center

Latest Stories

Obviously, the field of immune-oncology has been one of the great success stories in our field over the last five years, based on our molecular understanding of the mechanisms of immune tolerance (or checkpoints) and how to disrupt that. Not only has ASCO declared Checkpoint Inhibition (as well as cellular-based immunotherapy) the “Advance of the Year,” the Nobel Committee awarded this year's Prize to Drs. Allison and Honjo for their fabulous observations that led to these great breakthroughs.